Marsha Alpert Chandler, a director of Biocept, recently acquired 4,545 shares of the company. The buys took place at prices ranging from $0.00 to $1.10 per share, on dates ranging from March 04 to October 19, 2016. Chandler now owns 6,905 shares of the company. At least some of the disposals which took place during this transaction were gifts or donations. Chandler operates out of San Diego, CA. Some additional info was provided as follows:
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,333 fewer shares with respect to these shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 3,385 fewer shares with respect to thes
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Jonathan I. Cope just provided an update on share ownership of Biocept - Sept. 24, 2018
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 24, 2018
Biocept Announces Pricing Of $2.5 Million Registered Direct Offering Priced At Market - Sept. 24, 2018
Securities to be offered to employees in employee benefit plans - Sept. 10, 2018
SVP of Biocept just declared ownership of no shares of Biocept - Sept. 7, 2018